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EXECUTIVE SUMMARY

Ely, Jona. Evaluation of the Use of Electric Cigarettes in a Rural Smoking Cessation
Program. Unpublished Doctor of Nursing Practice Capstone Project, University
of Northern Colorado, 2013.
The purpose of this Doctor of Nursing Practice capstone project was to evaluate a
structured rural smoking cessation program that integrated electric cigarettes as an
additional option to other standard interventions. The aims of the program evaluation
were to develop an evaluation design and methodology to guide data collection and
analysis, analize findings, and provide recommendations regarding the current program
and future usage or changes.
The Donabedian and bridge evaluation models provided the framework to
evaluate the smoking cessation program, make recommendations for future applications,
potential improvements, and determine elements of the program that should be continued
in its current state.
After obtaining Institutional Review Board approval, 44 participants were
recruited to participate in the smoking cessation program evaluation. The results
indicated 14 (32%) quit smoking and seven (16%) switched to e-cigarettes. Of the
remaining 23 participants, 13 (30%) successfully cut down to less than half of their
starting tobacco use level with the use of e-cigarettes. Of the 14 participants who quit, 10
used e-cigarettes exclusively and the other four also used Bupropion (two) or Chantix
(two). Of the seven who switched to e-cigarettes, three used only e-cigarettes and four
used e-cigarettes and Bupropion. Of the 13 participants who cut down to less than half of
iii

their starting amount of tobacco cigarettes, seven were only using e-cigarettes and six
were using e-cigarettes and Bupropion. Program participants’ success rate at cessation or
switching to e-cigarettes exclusively was double both the national and state averages of
21-24%, resulting in a significant harm reduction for patients and families.
Recommendations from the evaluation included continuing the program with
modifications to educational materials and follow up strategies, using different types of
staff for implementation, and using the program as a model for other agencies or
organizations.
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CHAPTER I

STATEMENT OF THE PROBLEM

Background and Significance
Tobacco use remains the leading preventable cause of death, disease, and
disability in the United States (National Institute on Drug Abuse [NIDA], 2010). A 2012
report from the Center for Disease Control and Prevention (CDC) indicated that the
adverse effects related to smoking account for an estimated 443,000 deaths (or nearly one
in five deaths) each year in the United States. Exposure to secondhand smoke can also
cause death and diseases (NIDA, 2010). Every year 126,000 Americans are exposed to
secondhand smoke and almost 50,000 nonsmokers die from diseases related to
secondhand smoke annually. A 2009 Morbidity and Mortality report (CDC, “Morbidity
and Mortality Report”) indicated that in 2008, an estimated 20.6% (46 million) adults in
the United States were current cigarette smokers; among those, 45.3% (20.8 million) had
stopped smoking for one day or more during the preceding 12 months in an attempt to
quit.
Smoking cessation is challenging and frequently requires multiple attempts before
an individual is able to quit. Switching from tobacco cigarettes to a nicotine replacement
therapy (NRT) is standard practice in smoking cessation programs. However, most
smokers do not find the current NRT products to be as satisfying as cigarettes as they
provide nicotine at doses and rates of delivery that are a poor substitutes for cigarettes
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(Houezec, McNeill, & Britton, 2011). There is a promising new smoking cessation aide
on the market called electronic cigarettes (e-cigarettes). An e-cigarette is an electrical
device that attempts to simulate the act of smoking a tobacco cigarette. Most of them are
composed of a rechargeable, battery-operated heating element, a replaceable or refillable
cartridge, and an atomizer that converts the contents in the cartridge to vapor that is
inhaled by the user. Multiple choices for the strength of nicotine in the liquid or the
cartridges range from placebo to full strength (24 mg) and are also available in multiple
flavors. The e-cigarette alleviates the health risks related to second hand smoke and
promises to be far more effective at increasing the success rate of tobacco cessation.
Problem Statement
Primary care providers in a rural northern Colorado region noted that in their
community-based practice, smoking rates and related health problems were higher than
both the state and national averages (CDC, 2012). After the realization that there were
very few available resources to assist local residents with smoking cessation, a program
was developed and implemented in a selected rural primary care setting that offered the
e-cigarette as an alternative means of NRT or harm reduction. The e-cigarette was
chosen as the alternative method in response to the poor success rate and potential
adverse side effects of the current approved smoking cessation options. For a smoker, the
health risks of continuing to smoke tobacco cigarettes far outweigh the risks of any NRT
they might choose including e-cigarettes (Cobb, Byron, Abrams, & Shields, 2010;
Tobacco Vapor Cigarette Association [TVECA], 2010). Although the smoking cessation
program was developed with implementation goals and objectives, no systemic formal
evaluation plan was included. This capstone project was initiated to create and perform
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an evaluation plan for the smoking cessation program and to make recommendations for
current and future participants in this program.
Purpose
The purpose of this DNP capstone project was to evaluate a structured smoking
cessation program that integrated e-cigarettes as an additional option to other standard
interventions. The aims of the program evaluation were to develop an evaluation design
and methodology to guide data collection and analysis, analyze findings, and provide
recommendations regarding the current program and future usage and/or changes.
Theoretical Frameworks
The Donabedian (1972) model and the bridge evaluation model (Sieloff, 1999)
were used to evaluate the program and provided the basis for this capstone project. These
two models served as the foundation for the evaluation plan to define and describe
objectives, describe and measure indicators of success, and utilize outcome
measurements. The Donabedian and bridge models provided the framework to evaluate
the program, make recommendations for future applications and potential improvements,
and determine elements of the program that should be continued in their current state.
Donabedian Model
The literature review of the Donabedian model revealed its use in multiple
program evaluations. According to Donabedian (1972), the definition of evaluation is
the use of scientific method and rigorous and systemic collection of research data
to assess the effectiveness of organizations, services and programs in achieving
predefined objectives For health services, it is used to see if they fulfill their
stated goals, targets or objectives. (p. 103)
It is based on the collection of data about the structure, process, and outcomes of the
service as well as the appropriateness of the service (Donabedian, 1972). Evaluations can
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be formative or summative. A formative evaluation involves the collection of data while
the program is active--the goal is is to develop or improve the program. A summative
evaluation involves collecting data about an active or terminated program--the goal is to
decide whether the program should be continued or repeated (Donabedian, 1972).
Program evaluation is the systemic investigation of the worth or merit of a
program. A program evaluation can show evidence of acheivement of program goals,
identify effective program components, determine why some program components are
effective while others are not, identify potential program improvements, and provide
information on a program’s cost effectiveness (Donabedian, 1972). The first step in a
program evaluation is to identify the purpose of the evaluation and develop evaluation
questions based on program inputs (processes) and expected outcomes. The next step is
to develop an evaluation design and methodology to guide data collection and analysis.
This requires identification of the data necessary to answer evaluation questions, methods
of data collection, sampling strategy, and data collection instruments (Donabedian, 1972).
The data are then analyzed, findings are interpreted, and recommendations are made.
The Donabedian model first originated in 1966 and has guided work regarding the
elements used to evaluate and compare health care quality for over four decades
(Donabedian, 1972; Mitchell, Ferketich, & Jennings, 1998). Donabedian’s (1972)
framework specifies that structure influences process, influences outcomes, and is easy to
use for theory testing and organizing data. For example, Donabedian’s model influenced
the Quality Assessment/Quality Assurance Movement of the 1970s, the Total Quality
Management Movement of the late 1980s, and more recent performance measurement
initiatives (Larson & Muller, 2002/2003). It was used to (a) evaluate patient satisfaction
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for diabetic patients (Westaway, Rheeder, VanZyl, & Seagar, 2003); (b) evaluate how the
structure and process affect the outcome in a nursing facility (Cook, 2002); (c) evaluate
the structure of models serving adults with mental retardation/developmental disabilities
(Pulcini & Howard, 1997); (d) apply the Donabedian model as the framework for
bariatric surgery (Smitz Naranjo & Viswanatha Kaimal, 2011); (e) evaluate patient
preception of nursing service quality (Kobayashi, Takemura, & Kanda, 2011); (f) review
the quality of care in systemic lupus erythematosus patients (Lawson & Yazdany, 2012);
and (g) assess patient satisfaction with quality of care in a large teaching hospital (Tasso
et al., 2002) to mention just a few examples.
The Donabedian (1972) structure-process-outcome model uses three criteria to
evaluate a health care program:
1.

Structure measures: Focus on conditions under which the care is provided
and evaluates the inputs and resources into the services. It is the
organizational framework for the activities that happen within the health
service.

2.

Process measures: Focus on what a health care provider does to maintain or
improve patients’ health. These are the activities themselves (i.e., screening,
diagnosis, treatment, education).

3.

Outcome measures: Focus on changes in health status that are attributable to
health care. They refer to the effectiveness of activities that are measured
by mortality and morbidity rates, complication rates, disability, quality of
life, and patient satisfaction. They measure the impact on patients and
communities.
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Bridge Evaluation Model
The bridge evaluation model was first implemented in 1999 by Debra Sieloff
(1999). “The bridge symbolism represents the structure over open waters (the evaluation
environment) that can transport the evaluation manager from the beginning of the
evaluation (the question) to the end (finding the answer to the question)” (Sieloff, 1999,
p. 14). The bridge also serves to illustrate the flexibility of the model (like two-way
traffic on a bridge): the evaluation manager can modify the evaluation plan, the data
collection tools, use of data, reporting methods, and post evaluation evaluation systems
much like a traveler can change directions on a bridge (Sieloff, 1999). The bridge
evaluation model could be used to “evaluate the worth or merit of any form of program,
problem, service, product, or issue” (Sieloff, 1999, p. 15). This model could be used to
identify the judgement methods including defination of standards and collection of
relevant data. It could then be used to apply the standards to determine the value, quality,
utility, effectiveness, or significance of the evaluation’s objective.
Based on the work of Worthen, Sanders, and Fitzpatrick (1997), the bridge
evaluation model illustrates the process and factors that determine the outcome of an
evaluation. This model illustrates the evaluation process and the following elements
(Sieloff, 1999):
1.

Plan/design: Define the purpose, use, type, approach, resources, reporting
methods, protocol, and schedule.

2.

Data collection: Include new and existing data. Gather both qualitative and
quantitative data using methods that will achieve the evaluation objective,
are unbiased, and appropriate.

7
3.

Testing and Assessing: Data, data resources, situational context, reliability,
and accuracy. Test validity, completeness, and correctness of data. Look at
such things as rival information, exceptions, varying perspectives from
observers, discrepancies, reactions, and evaluator effects.

4.

Report the evaluation findings. Include introduction, evaluation,
conclusion, and recommendations that incorporate an assessment of the
achievement of objectives, violation of any ethical or legal principles,
alterations of original evaluation needs, value of the evaluation’s
accomplishment, process and outcome of the data testing, expectations to
identify performance levels, and results achieved via the evaluation system.

5.

Evaluation: Test the usefulness or identify learning opportunities for future
applications.

The Donabedian (1972) and bridge evaluation models (Sieloff, 1999) provided
the framework to evaluate the smoking cessation program, make recommendations for
future applications, potential improvements, and determine elements of the program that
should be continued in its current state. These frameworks provided a concise, easy-tofollow structure to identify the objectives, collect the data, evaluate the tools used to
collect the data, evaluate whether the objectives were met, and provide recommendations
for changes and future use (Donabedian, 1972, Sieloff, 1999).

CHAPTER II

PROJECT DESCRIPTION AND DESIGN

Literature Review and Supporting Data Synthesis
Tobacco Use and Smoking Cessation
More deaths are caused by cigarette smoking each year than from all other causes
including human immunodeficiency virus (HIV), alcohol and drug use, motor vehicle
injuries, and murders and suicides combined. The Centers for Disease Control and
Prevention (CDC; 2011) reported that smoking causes an estimated 90% of all lung
cancer deaths in men, 80% of lung cancer deaths in women, and an estimated 90% of all
deaths related to chronic obstructive lung disease. Smoking also increases the risk of
coronary heart disease and stroke by two to four times compared to nonsmokers. The
report also indicated that cigarette smoking reduces circulation in the body by narrowing
blood vessels and puts smokers at risk for developing peripheral vascular disease and
abdominal aortic aneurysms. Cigarette smoking causes multiple lung diseases including
emphysemia, bronchitis, asthma exacerbations, and chronic airway obstruction, and is
also associated with lower bone density and an increased risk of hip fractures (CDC,
2012). In women, cigarette smoking has also been shown to increase infertility, preterm
delivery, stillbirth, low birth weight, and sudden infant death syndrome (CDC, 2012).
In the state of Colorado, the highest rate of smoking occurs in adults age 18-44.
Smoking prevalence is the highest in adults with a high school education level or lower,
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those living below the federal poverty level, and those with other substance abuse
problems (CDC, 2009). American Indians have the highest incidence of smoking at
36.1%, followed by Caucasians at 16.5% (CDC, 2011).
There are currently five different nicotine replacement therapies (NRT) approved
for use by the Food and Drug Administration: nicotine chewing gum, transdermal
patches, nasal sprays, inhalers, and lozenges. All of the current NRTs have been shown
to have similar efficacy and side effect profiles (Stead, Perera, Bullen, Mant, &
Lancaster, 2008). Prescription medications approved to help with tobacco cessation
currently include bupropion (Zyban) and varenicline (Chantix). Bupropion reduces the
symptoms of nicotine withdrawal, is usually well tolerated, and can be taken with NRTs
(American Cancer Society, 2011). Varenicline is a newer prescription medication and
works by interfering with nicotine receptors in the brain. Varenicline can be very
effective at helping with tobacco cessation but has multiple reported side effects:
headaches, nausea, vomiting, trouble sleeping, unusual dreams, flatulence, changes in
taste, depressed mood, changes in behavior, and thoughts of or attempted suicide
(American Cancer Society, 2011). It is also expensive with poor coverage on most
prescription plans.
According to the CDC in 2009, the success rate for an individual attempting to
quit “cold turkey” was between 4% to 7%. Any of the NRTs could double this number
from 8% to 14%; Bupropion could increase the cessation rate by approximately 20% and
Varenicline by approximately 33%. The success rate with combination therapies is still
only approximately 25% (CDC, 2009). This means that three out of four smokers will
still fail in their attempts to quit smoking. Users most often relapse due to withdrawal
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symptoms, stress, and weight gain. Although nicotine is extremely addictive and can be
toxic if ingested in large doses, it does not cause cancer. The complex mixture of
chemicals in tobacco is the known carcinogen. There are over 7,000 chemicals in
tobacco cigarettes and over 70 of them have been proven to be carcinogenic (CDC,
2009).
Electric Cigarettes
E-cigarettes offer a novel approach to smoking cessation as they can be used long
term, deliver a dose of nicotine that can be decreased gradually until at placebo level, are
significantly cheaper than tobacco cigarettes, and mimic cigarette smoking activities so
the smoker does not have to give up his or her behavior. By using an e-cigarette instead
of a tobacco cigarette, an individual can still ingest the same amount of nicotine but none
of the 7,000 carcinogens found in tobacco cigarettes.
An extensive literature review revealed a limited number of studies that
specifically evaluated the use of e-cigarettes for smoking cessation. The three studies
that were found were double blind, randomized, and had no stockholder involvement
(Cahn & Siegel, 2010; Eisenberg et al., 2008; Stead, Perera, Bulle, Mant, & Lancaster,
2008). No evidence was found indicating e-cigarettes caused or contributed to increased
harm. All of the available studies that did test the contents of e-cigarettes indicated they
were much safer than tobacco cigarettes (Bullen, Thornley, Glover, Lin, & Laugensen,
2010; Cahn & Siegel, 2010; Foy, Bombick, Doolittle, Mosberg, & Swauger, 2004;
Laugesen, 2008; Meckley et al., 2004; Patskan & Reininghaus, 2003; Roethig, Kinser,
Lau, & Wang, 2005; Stabbert et al., 2003; Terpstra et al., 2003; Tewes, Meisgen, Veltel,
Roemer, & Patskan, 2003;Werley et al., 2008). Most of the studies found no harmful
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chemicals in e-cigarettes; the few that did find trace amounts of carbon monoxide and
diethylene glycol were between a 500-fold to 1400-fold reduction in the concentration of
that found in tobacco cigarettes (Cahn & Siegel, 2010).
A report from the U.S. Food and Drug Administration (USFDA; 2010) tested two
different e-cigarettes and found nicotine in both products and very low levels of tobaccospecific nitrosamines and impruities. However, the report failed to present standard
protocols for proper study design with regard to the testing of the control device (nicotrol
inhaler), documenting the number of samples tested, and failed to present statistical
analyses when quantifiable results were obtained. The FDA stated the level of impurities
found was not quantifiable and was below the limit of quantification (WebMD, 2011 ).
A review of the consumer literature revealed approximately 90% of e-cigarette
users were attempting to quit smoking and all had previously smoked tobacco cigarettes
(All Electronic Cigarette Brands: Comparisons and Reviews, 2011; Etter, 2010). An
extensive literature review found no studies that actually used e-cigarettes as a smoking
cessation aide in a structured smoking cessation program. The significant gap in the
literature indicates a need to further investigate this product which is currently on the
market and being used by consumers. This capstone project could prove to be a starting
point to evaluate the efficacy of ecigarettes as a smoking cessation aide. The literature
did show there was extensive information and feedback on comsumer review sites that
indicated e-cigarettes were used frequently and effectively as a smoking cessation aide
(All Electronic Cigarette Brands, 2011).
The greatest concerns and complaints from consumer reviews were the variations
in the dosage of nicotine delivered, technical/mechanical defects or failure of the e-
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cigarettes, and lost effectiveness toward the end of use of the cartridge (All Electronic
Cigarette Brands, 2011). Over 40 brands of e-cigarettes were identified; the starter kits
ranged in price from $30 to $200 (see Table 1). The cost of the nicotine cartridges or
liquid nicotine is $2.00 versus the average $5.00 for a pack of tobacco cigarettes (All
Electronic Cigarette Brands, 2011). After a thorough review of multiple brands of ecigarettes, the brands BluCigs (2012) and SmokeTip (2012) had the best consumer
review ratings and were the e-cigarette brands recommended in this program. Both
brands scored at least a four out of five on five different areas: battery, vapor, service,
cost/value, and overall from over 200 reviews. Both brands are made in the United States
and the nicotine cartridges are made from FDA approved ingredients. The BluCig has a
one year warranty and the SmokeTip has a lifetime warranty. Both brands come in a
variety of flavors and nicotine doses and both offer free shipping to anywhere in the
United States (BluCigs, 2012; SmokeTip, 2012). The cost analysis data indicated the
only smoking cessation alternative cheaper than e-cigarettes was Bupropion. As
discussed earlier, Bupropion has a 24% success rate (CDC, 2009).
The literature review supported the need for more rigorous research using double
blind, randomized controlled trials and meta-analyis evaluating the safety and efficacy of
e-cigarettes for use in tobacco cessation. In addition, current research demonstrates the
need for more systematic regulation of e-cigarette manufacturers regarding the technical
quality of their products. After a review of the evidence available thus far, it is apparent
that e-cigarettes provide a greater benefit as an intervention for smoking cessation than a
risk for added harm. They show significant potential to increase the smoking cessation
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rate as smokers will not have to give up their behavior or their nicotine until they are
ready.

Table 1
Cost Analysis of Nicotine Replacement Therapy and Prescription Medications for
Smoking Cessation
Replacements

Cost Per Day

Cost Per Month

Nicotine Patches

Average $2.70-$4.70 each/
use 1 per day

Average $81-$141 per month

Nicotine Gum

Average $0.35-$0.63 each/ chew
1 every 1-2 hours

Average $126-$227 per month

Nicotine Lozenges

Average $0.49 each/
suck on one every 1-2 hours

Average $177 per month

Nicotine Oral Inhaler

$7.80 per day

$234 per month

Nicotine Nasal Inhaler

$6.66per day

$200 per month

Bupropion Oral Medication

$0.90-$1.66 per day

$27-$50 per month

Varenicline Oral Medication

$5.96-$6.4 per day

$179-$192 per month

BluCig

$2.00 per day

$60 per month

SmokeTip

$1.59 per day

$47.70 per month

Note. In store cost analysis done February 2012 at Walgreens and Walmart, Craig, Colorado.
Information based on 1 pack per day/smoker.

Description of the Kinder Family Clinic Smoking
Cessation Program and Population
Kinder Family Clinic is a rural physician-owned health care clinic that serves the
residents of Moffat County and multiple surrounding areas of northwestern Colorado. It
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is one of few health care resources in the area and offers care to all ages for both acute
and chronic problems. Many of the acute and chronic problems are caused by or
exacerbated by tobacco use. The Kinder Family Clinic Smoking Cessation Program was
implemented in response to the poor cessation rates related to current smoking cessation
therapy options and offers an alternative therapy for smoking cessation as a means for
harm reduction for those individuals who are not interested in quitting but would be
willing to switch to e-cigarettes as an alternative to smoking regular tobacco cigarettes.
This rural area is extremely limited regarding access to smoking cessation treatment and
education. The Kinder Family Clinic Smoking Cessation program was a six month
program implemented on a trial basis and will be continued or changed based on this
program evaluation. The program included established patients who were current
smokers who chose to participate.
Theoretical Framework Used for the
Smoking Cessation Program
The transtheoretical model (TTM; Prochaska & DiClemente 1983; Prochaska,
DiClemente, & Norcross, 1992; Prochaska, DiClemente, & Velicer, 1985) and the five
stages of change originally developed by James Prochaska provided the foundation for
the Kinder Family Clinic Smoking Cessation Program. The TTM provided a structured
evidence-based framework to assist in evaluating an individual’s readiness to quit
smoking and support for the smoking cessation process (Woody, DeCristofaro, &
Carlton, 2008). The stages of change described in the model represent a time period as
well as a set of tasks needed to move from one stage to the next. There are five stages of
change; for each stage, different change processes and relational stances provide optimal
progress. Individuals typically recycle through these five stages an average of three to
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four times before they actually overcome their addiction (Prochaska, 1992; Prochaska &
DiClemente, 1983; Prochaska et al., 1985; Prochaska, Velicer, DiClemente, & Fava,
1988). The five stages included the following:
1.

Precontemplation: The individual has no intention to change their behavior.
Individuals in this stage are unaware or under-aware that they have a
problem. However, family, friends, and employers are well aware that the
patient has a problem.

2.

Contemplation: The individual has some intention to change but no
behavior. Individuals in this stage are aware that they have a problem, are
seriously thinking about overcoming it, but have made no effort or
commitment to change. Many individuals in this stage struggle with
positive evaluations of their dysfunctional behavior and the amount of
effort, energy, and loss they feel to overcome their problem. They may
remain stuck in this stage for a long period of time.

3.

Preparation: The individual intends to change and early inconsistent
behavioral attempts to change are made. Individuals in this stage have made
some reduction in their problem behavior, intend to take action within the
next month, but have not yet reached the point for effective action.

4.

Action: The individual has consistent behavioral performance for less than
six months. This is the stage where an individual is modifying their
behavior to overcome the problem. The action stage requires considerable
commitment of effort and energy to change the behavior. An individual is
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classified in this stage if they have quit their behavior for a period from one
day to six months.
5.

Maintenance: The individual has had consistent behavioral performance for
at least six months. This is the stage where the individual must work to
prevent a relapse and is consistently engaging in a new positive,
incompatible behavior. This period extends from six months to an
indeterminate period (Prochaska 1992; Prochaska & DiClemente, 1983;
Prochaska et al., 1985, 1988).

The majority of addicted individuals are not in the action stage (Prochaska 1992;
Prochaska & DiClemente, 1983; Prochaska et al., 1985, 1988). Only 10-15% of smokers
are prepared for action, approximately 30-40% are in the contemplation stage, and 5060% are still in the precontemplation stage. The amount of progress an individual makes
during treatment tends to be a function of their pre-treatment stage. To treat all smokers
as if they are all in the same stage is naïve, yet that has been the approach used in most
traditional treatment programs (Prochaska et al., 1992). Treatment programs designed to
help individuals progress just one stage in a month can double their chances of taking
action on their own (Prochaska et al., 1992). Relapes are almost inevitable and are part
of the process of working toward life-long change (Zimmerman, Olsen, & Bosworth,
2000). Effective treatment programs need to assess an individual’s stage of readiness for
change and tailor interventions accordingly (Prochaska et al., 1992).
The concepts of addiction were used as a secondary framework for this smoking
cessation program. Nicotine addiction is the most common form of chemical dependence
in the United States (American Society of Addiction Medicine, 2008). Addiction is
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important to take into account when designing smoking cessation interventions as
withdrawal symptoms impede quitting (Andersen, 2007). Avoiding withdrawal
symptoms is the number one reason why individuals fail in their attempt at smoking
cessation (Andersen, 2007). Nicotine replacement therapy is an effective way to deal
with the physiological addiction to tobacco as it prevents nicotine withdrawal symptoms
(Andersen, 2007).
Smoking Cessation Program Objectives
The main objective of this program was to offer a new smoking cessation option
that could dramatically improve the overall smoking cessation rate of all populations.
The second objective was to provide an alternative to tobacco cigarettes for those
individuals not interested in quitting smoking but willing to switch to a much safer and
cheaper alternative.
Implementation Methods and Tools Used for Program
Participant Recruitment
The goal was to recruit patients from Kinder Family Clinic Practice and the
surrounding community who were willing to participate in the program. The objectives
were as follows:
1.

Identify Kinder Family Clinic patients who are current smokers using the
clinic’s electronic health record (EHR) system--“Practice Partner.”

2.

Send a survey to those patients identified as current smokers (see Appendix
A). Based on return survey results, identify patients willing to participate in
the program who wished to quit or who were willing to switch from tobacco
cigarettes to e-cigarettes.
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3.

Provide each participant with informed consent regarding program to read
and sign prior to participation (see Appendix B for consent and Appendix K
for Institutional Review Board approval).

Pre-intervention Assessment
The goal was to obtain pre-intervention assessments of participants to determine
smoking history, demographics, likelihood to change and be successful, and baseline
nicotine dose. The objectives were as follows:
1.

Evaluate participants’ stage of change, smoking status, length of time they
smoked, number of cigarettes per day, previous attempts to quit, past
interventions used for smoking cessation, and demographic information
including age, gender, education level (a former smoker was defined as an
individual who was actively trying to quit and had not smoked in at least 24
hours).

2.

Build The Stages of Change questions (see Appendices C and D) into the
smoking cessation template in Practice Partner EHR and use as the
framework for this program to assist in evaluating an individual’s readiness
to quit smoking. Knowing which stage of change an individual is in was
thought to help tailor the information and guidance provided to maximize
success with smoking cessation.

3.

Evaluate nicotine dependence using the revised Fagerstrom nicotine
tolerance test (FNTT; Heatherton, Kozowski, Frecker, & Fagerstrom, 1991).
This test was used to determine the baseline nicotine dose for e-cigarettes
for smoking cessation (see Appendix E).
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Intervention
The goal was the implementation of a structured, systematic smoking cessation
program using the “Five A’s” model for treating tobacco use and dependence to include
options to either help smokers quit entirely or switch from tobacco cigarettes to electric
cigarettes (see Appendix F). The objectives were as follows:
1.

Develop program by reviewing current literature for best practices in
smoking cessation related to addiction, frameworks for behavior change,
nicotine replacement therapies and prescription medications, and patient
education.

2.

Adopt and adapt selected education materials based on the "5 A's" model
(see Appendix F) for treating tobacco use and dependence developed by the
Colorado Collaborative Clinical Guidelines (2004).

3.

Provide staff development and education regarding program details, patient
data, and Practice Partner EHR prior to implementation.

4.

Discuss options for smoking cessation with each participant at initiation of
program and allow the participant to choose which cessation method he or
she would like to try. Provide written information on different cessation
options, success rate, risks, and benefits at the initiation of the program (see
Appendix G).

5.

Provide written information on dangers of smoking and benefits of quitting,
support, and resources to help with quitting at the initiation of program to
each participant (Colorado Collaborative Clinical Guidelines, 2004).
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6.

Develop a plan and timeline to decrease nicotine dose based on nicotine
dependence, personal preference, desire to quit, and health risks for each
participant and evaluate their nicotine dose during each follow-up phone
call.

7.

If the participant chooses to try e-cigarettes, provide written information on
BluCig and SmokeTip e-cigarettes (the two e- brands recommended for this
program) regarding cost, availability, and nicotine dosage options (see
Appendices H and I).

8.

Develop and implement a follow-up plan that integrates phone calls or
office visits for each program participant at two weeks, one month, three
months, and six months. Document follow-up data in Practice Partner EHR
(see Appendix J) that includes evaluation questions regarding smoking
status, nicotine dosage, e-cigarette likability, usage, and comments.

Tools Used in Program
•

The five stages of change used as the framework for this project (precontemplation, contemplation, preparation, action, and maintenance)
provided a structured evidence-based framework to assist in evaluating an
individual’s readiness to quit smoking and support for the smoking cessation
process (see Appendix D). Knowing which stage of change an individual
was in helped tailor the information and guidance provided to maximize
success with smoking cessation. It was used to help predict the individual’s
success rate at smoking cessation (see Appendices C, D, and F).
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•

The revised Fagerstrom Test for Nicotine Dependence (FTND; Heatherton
et al., 1991) was used to assess each participant’s degree of physical
dependence on nicotine. The Fagerstrom Tolerance Questionnaire (FTQ;
Fagerstrom, Hughes, Rasmussen, & Callas, 2000) is a 10-item questionnaire
and the questions are scored on a 5-point Likert scale; the total score is the
mean rating across all 10 items. The assumption was the higher the score
the greater the degree of addiction. The questions were used to assess the
degree of urgency an individual felt to restore nicotine levels to a given
threshold after nighttime abstinence and to evaluate the urge the individual
had to maintain their nicotine threshold during waking hours. This test was
used to evaluate the baseline nicotine dose for NRT or e-cigarette for
smoking cessation (see Appendix E).

•

Pre-intervention surveys were completed by participants at onset of program
regarding demographic information, smoking history, previous quit
attempts, and methods tried.

•

Education material on the effects of smoking and benefits of quitting
accessed through the Colorado Collaborative Clinical Guidelines (2004)
were provided to each patient at the initiation of program.

•

Informational material was provided to participants regarding effectiveness,
cost, and potential side effects of different cessation methods at initiation of
program.

•

Information on the two chosen e-cigarettes (BluCig and SmokeTip) that
were used in this program regarding cost, nicotine doses and flavors, and
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accessibility was provided to participants at initiation of the program (see
Appendices H and I).
•

Phone calls to participants during implementation and at completion of
program regarding smoking status, decrease in number of cigarettes if still
smoking, nicotine level if using e-cigarette, type of e-cigarette they chose,
and comments regarding e-cigarette likability, usability, durability.
Program Evaluation Objectives and Design

The objectives of this capstone project were to evaluate the Kinder Family Clinic
Smoking Cessation Program using the Donabedian and bridge evaluation models
regarding its structure, processes, and outcomes (Donabedian, 1972; Sieloff, 1999).
These theoretical frameworks provided the foundation for evaluating the extent to which
the program met each specified goal and objective, possible barriers and facilitators, and
recommendations for future improvements.
Donabedian Model
Structural measures evaluated the facility or setting used, human resources
including qualifications and experience, and the organizational resources including the
Practice Partner EHR and size of the practice and program.
Process measures evaluated for this program included the screening, treatment,
education, and follow-up phone surveys of participants.
Outcome measures evaluated for this program included participation level,
demographic data of participants, success rate of participants, e-cigarette data, and
improvement to quality of life.
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Bridge Evaluation Model
By incorporating the bridge evaluation model into the evaluation process, human
factors critical to an evaluation’s success were also taken into account. According to
Sieloff (1999), the bridge evaluation model included the following:
1.

Goal Identification: What is to be evaluated? What problem is the
evaluation intended to address? What is the purpose of the evaluation?
How can the essential program activities be linked to the goal? How do
time and resource factors affect the evaluation goal?

2.

Interpersonal Relationships: Will the interpersonal relationships support the
efficient and effective implementation of the evaluation plan? What kind of
communication might improve the evaluation implementation and reporting
system? What kind of bias exists regarding the program being evaluated
and those who can influence the evaluation design, data, and use?

3.

Ethics: What are the essential program activities and are they legal/ethical?
How will the type and use of data be collected for the evaluation? How and
by whom will the information be used? What use will the evaluation
findings serve and is it ethical?

4.

Politics: Why is the evaluation being requested? Who will participate and
what are their roles in the evaluation? What political use will the evaluation
findings serve, if any? Who else needs to know about the evaluation
findings (e.g., stakeholders)?
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5.

Determination: Can the evaluation design meet the evaluation goal given the
scope and context of the evaluation’s purpose? Who will use the evaluation
findings? How will the determination affect stakeholders?

Bridge Model Technical Factors
1.

Design: Create an evaluation plan and design the evaluation system in
accordance with the goals. This could include criteria and objectives, type
of evaluation (formative or summative), evaluator, purpose, evaluation
approach, data-collection requirements-tools-protocol, resources and
supplies, environmental considerations, and reporting methods.

2.

Collect Data: Gather qualitative or quantitative data in accordance with the
evaluation plan using methods that achieved the objectives. This could
include survey instruments, private interviews, group interviews, previously
collected related data, and observations including tests and document
review.

3.

Test/Assess: Synthesize the findings from the qualitative and quantitative
methods to test the validity, completeness, or correctness of the data.

4.

Report: Prepare the report for the target audience in accordance with the
evaluation plan to include the introduction, evaluation, conclusions, and
recommendations. This might include achievement of evaluation
objectives, noted violations of ethical principles, alterations in the original
evaluation needs, value of the evaluation’s accomplishment, the process and
outcomes of the data assessment, and results achieved via the evaluation
system.
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5.

Evaluation Results: Perform an evaluation on the effectiveness of the
evaluation using the model.
Congruence of Organization’s
Strategic Plan to Project

Kinder Family Clinic was completely supportive of this program with the focus
on improving the health of the community. The clinic is a private physician-owned
health care clinic in rural northwest Colorado located in Craig. Kinder Family Clinic is
staffed by a Family Nurse Practitioner, Dr. Pamela Kinder, who is a neurologist and the
owner of the clinic; two receptionists; and two medical assistants. The clinic seeks to
expand family practice patients and focus on health promotion and disease prevention
practices and programs. The mission statement for Kinder Family Clinic is to provide
excellent care in a nurturing, welcoming environment to the people of the Yampa Valley.
The goals of Kinder Family Clinic are (a) to provide quality care for each patient; (b) to
recognize, respect, and appreciate each team member’s individuality and talents; (c) to
utilize the skills of each individual; (d) to have more understanding of our patients’
needs; to have a safe and healthy working environment; and (e) to make Kinder Family
Clinic successful. The visions for the future for the clinic are (a) to work to become
increasingly recognized as providing the highest quality care available in the profession
as measured by patient satisfaction and cost effectiveness; (b) to provide leadership in the
community by actively participating in professional and community groups; and (c) to
commit to excellence and respond to our patients with a level of care that exceeds their
expectations (Kinder Family Clinic, 2011).
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Resources
Resources needed to implement program into Kinder Family Practice included the
following:
•

Patient questionnaire on stages of change, addiction level, baseline nicotine
dose, and demographic data. It was provided to each participant to complete
at initiation of program and was also built into the Smoking Cessation
Template in Practice Partner (Kinder Family Clinic, 2011).

•

Educational material on effects of smoking and benefits of quitting prepared
by Colorado Collaborative Clinical Guidelines (2004) were provided to each
participant at initiation of program.

•

Informational material on all options for smoking cessation including
effectiveness, cost, and potential side effects provided to each participant at
initiation of program (see Appendix G).

•

Information on BluCig and SmokeTip e-cigarette regarding cost of kit and
replacement nicotine cartridges, doses and flavors of nicotine cartridges, and
where it can be purchased (see Appendices H and I) were provided to each
participant at initiation of program.

•

Time to send survey, review responses, and contact participants of program.
Risks

No risks were identified related to the use of electric cigarettes compared to
tobacco cigarettes; the data show them to actually reduce the health related risks seen
with tobacco cigarettes.
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Benefits
E-cigarettes could become a new option to help with smoking cessation if proven
to be effective, diminishing or alleviating the risks associated with tobacco cigarettes and
second-hand smoke. E-cigarettes are also cheaper than tobacco cigarettes and many of
the other smoking cessation options, which would be more financially beneficial to
individuals.

CHAPTER III

EVALUATION PLAN

The evaluation plan provides a systematic outline of the processes implemented to
meet the aims of the program evaluation and include the following:
1.

Clear identification of the purpose of the evaluation

2.

Evaluation questions based on program structure, inputs (processes) and
expected outcomes

3.

Design and methodology to guide data collection and analysis

4.

Recommendations based on the interpretation of the data analysis
Purpose of the Evaluation

The purpose of this evaluation was to determine achievement of program goals,
identify effective program components, determine why some program components were
effective while others were not, identify potential program improvements, and provide
information on the program’s cost effectiveness and outcomes. The Donabedian (1972)
and bridge (Sieloff, 1999) models were used as a framework to guide the elements of the
evaluation.
The following questions guided the program evaluation and were answered
through collection and analysis of specific data:
Q1

Were the stated goals and objectives of the program met, not met, or
partially met?
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Each program goal (outlined in Chapter II) was assessed based on appropriate and
applicable data (see Table 2).
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Table 2
Program Goals and Objectives
Goal

Objective

Recruit patients from Kinder
Family Clinic Practice and
the surrounding community
who were willing to
participate in the program.

•
•

•

Obtain pre-intervention
assessment of participants to
determine smoking history,
demographics, likelihood to
change and be successful,
and baseline nicotine dose.

•

•

•

Implementation of a
structured, systematic
smoking cessation program
using the “Five A’s” Treating
Tobacco Use and
Dependence to include
options to either help
smokers quit entirely or
switch from tobacco
cigarettes to electric
cigarettes (Appendix F).

•
•

•
•

•
•
•

•

Identify Kinder Family Clinic patients who are current smokers using the
clinic’s EHR system “Practice Partner”.
Send a survey to those patients identified as current smokers. (Appendix A).
Based on return survey results, identify patients who were willing to
participate in the program who wished to quit, or who were willing to switch
from tobacco cigarettes to e-cigarettes.
Provide each participant with informed consent regarding program to read and
sign prior to participation.
Evaluate participants’ stage of change, smoking status, length of time they
smoked, number of cigarettes per day, previous attempts to quit, past
interventions used for smoking cessation, demographic information including
age, gender, education level. (A former smoker was defined as an individual
that was actively trying to quit and had not smoked in at least 24 hours.)
Build The Stages of Change questions (Appendix C), into the smoking
cessation template in Practice Partner EHR, and use as the framework for this
program to assist in evaluating an individual’s readiness to quit smoking.
Knowing which stage of change an individual is in was thought to help tailor
the information and guidance provided to maximize success with smoking
cessation.
Evaluate nicotine dependence using the Fagerstrom Nicotine Tolerance Test
(FNTT). (This test was used to determine the baseline nicotine dose for ecigarettes for smoking cessation (Appendix E).)
Develop program by reviewing current literature for best practices in smoking
cessation related to addiction, frameworks for behavior change, NRTs and
prescription medications, and patient education.
Adopt and adapt selected education materials based on The "5 A's" model
(Appendix F), for treating tobacco use and dependence that was developed by
the Colorado Collaborative Clinical Guidelines (Colorado Collaborative
Clinical Guidelines, 2004).
Provide staff development and education regarding program details, patient
data, and Practice Partner EHR prior to implementation.
Discuss options for smoking cessation with each participant at initiation of
program, and allow the participant to choose which cessation method he or she
would like to try. Provide written information on different cessation options,
success rate, risks, and benefits at the initiation of the program.
Provide written information on dangers of smoking and benefits of quitting,
support, and resources to help with quitting at the initiation of program to each
participant (Colorado Collaborative Clinical Guidelines, 2004).
Develop a plan and timeline to decrease nicotine dose based on nicotine
dependence, personal preference, desire to quit, and health risks for each
participant and evaluate their nicotine dose during each follow-up phone call.
If the participant chose to try e-cigarettes, provide written information on “blu
cig” and “smoke tip” e-cigarettes, which were the two e-cigarette brands
recommended for this program, regarding cost, availability, nicotine dosage
options.
Develop and implement a follow-up plan that integrates phone calls or office
visits for each program participant at 2 weeks, 1 month, 3 months, and 6
months. Document follow-up data in Practice Partner EHR (Appendix H) that
includes evaluation questions regarding smoking status, nicotine dosage, ecigarette likability, usage, and comments.
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Q2

Were the structural components (facility/setting, human resources,
organizatonal resources, EHR, tools) effective and how did they contribute
to the value of the program?

Table 3 presents the structural measures utilized to evaluate the collected data.

Table 3
Structural Measures
Evaluate

Data

Data Collection

Usefulness of written education on
smoking cessation.
1. Packet from Colorado
Collaborative Guidelines
2. Smoking Cessation Options
3. Cost Comparison of NRT
4. Information on Blu Cig and
Smoketip E-cigarettes

Subjective Data provided by program
participants on effectiveness of cessation
options, cost information, and whether it
was appropriate and adequate.

Phone interviews to all program participants
with focused questions regarding feedback
on program’s educational materials.

Electronic Health Records (EHR)
used for program “Practice
Partner”.

Usability and reliability of EHR for data
collection, management, and analysis

Determination by primary investigator and
staff at completion of program, based on
ability to collect and quantify necessary data
from EHR.

Staff education regarding Kinder
Family Clinic smoking cessation
program.

Staff education on program details, patient
data, and use of EHR for program.

In person survey of staff

Framework used for program.

TTM model (Stages of Change) used to
evaluate participants readiness to quit
smoking.

Stages of Change of participant collected at
initiation and completion of program.
Determination/ assessment by primary
investigator.

Fagerstrom Tolerance Test

Effectiveness, reliability, validity, and
accuracy of test regarding nicotine
addiction level of program participants.

Gather and evaluate data from preintervention survey and comments from
participants during follow up phone calls
regarding nicotine level.

Pre-participation Survey
1. Questionnaire
2. Mail Survey

Evaluate information collected on survey
regarding whether questions appropriate, all
inclusive, recommended additions, or
changes. Mail survey vs. other options for
communication (emails, text messages,
website).

Phone interview to participants with focused
questions.
Response rate to mail surveys, participant
and staff opinions and recommendations.

Phone calls as chosen method of
contact and follow-up with
participants.

Phone calls as appropriate and adequate
communication choice for program. What
other methods of communication could
have been used.

Response rate of participants to phone calls.
Participant and staff recommendations
regarding other options for communication.

Necessary qualifications of
program administrator/provider.

Qualifications of primary investigator.
What other staff could have been used to
implement this program and necessary
qualifications

Determination of primary investigator using
literature for context regarding needed
education level to implement and administer
program.

Program Sustainability and
Usability.

Recommendations on whether program
should continue, recommended changes,
and other potential settings for program.

Outcome data and cost analysis regarding
program use, changes, and other settings
appropriate for use.
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Q3

Were the processes used for the program effective and how did they
contribute to the value?

Table 4 presents the processes used to measure the effectiveness of the program.

Table 4
Process Measures
Evaluate

Data

Data Collection

Identify all current smokers at
Kinder Family Clinic and
those willing to participate in
smoking cessation program.

Were all current smokers
identified and were they all
sent an invitation to
participate in smoking
cessation program using ecigarettes.

Use Practice Partner EHR to
identify current smokers,
identify those willing to
participate based upon results
from return survey.

Usefulness of The Stages of
Change and participation in
program.

Was this particular model
useful for determining
participation in program?

Stage of change of
participants at initiation and
completion of program. Was
the model applicable to the
study participants and did it
provide a framework for the
implementation/ intervention?

Usefulness of determining
nicotine addiction level of
participants at initiation and
completion of program.

Determine nicotine addiction
level to determine appropriate
baseline nicotine dose for ecigarette.

Use the Fagerstrom Tolerance
Test to determine nicotine
level, correlation with
participant self-report.

Phone Call Follow-up
Response of participants.

Were phone follow ups at 2
weeks, 1month, 3months, and
6 months effective and did
they contribute to the
participant’s overall success?

Use EHR and excel
spreadsheet to evaluate phone
contact with each participant.

Q4

What were the outcomes of the program and how do they compare with
anticipated outcomes and outcomes of other standard practices?

Table 5 presents how the outcomes of the program were measured and how they
compared with anticipated outcomes.
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Table 5
Outcome Measures
Evaluate

Data

Data Collection

Current smokers that are patients
at Kinder Family Clinic and
participants in program.

Number of current smokers and
number of participants of
program.

Use EHR and excel spreadsheet
to collect data.

Demographic information of
participants

Age, gender, ethnicity, race, and
education level of participants.

Quantify data gained from preparticipation survey and EHR.

E-cigarettes
1. Smoking cessation rate of
participants at completion of
program that had not
smoked in at least a month.
2. Participants that switched
from tobacco cigarettes to ecigarettes.
3. Participants that decreased
use of tobacco cigarettes to
at least less than half of
usage from initiation to
completion of program by
using e-cigarettes.

Cessation rate, and harm
reduction rate of participants.

Data obtained from phone call
f/u with participants, use EHR
and spreadsheet to quantify data.

Nicotine addiction level of
participants

Nicotine level of participants at
initiation and completion of
program using Fagerstrom
Tolerance Test.

Data obtained from preintervention survey and phone
call follow up with participants,
use EHR and spreadsheet to
quantify data.

Participant perspectives
regarding e-cigarettes.

Document comments regarding
e-cigarette satisfaction,
effectiveness, cost, reliability,
accessibility, and improvement
on quality of life.

Data obtained from phone call
f/u with participants, use EHR
and spreadsheet to quantify data.

Q5

Was the program cost effective?

The following costs and/or revenue were related to the program: (a) human
resources or time spent collecting “current smoker status” on Kinder Family Clinic
patients from Practice Partner EHR; (b) time spent on copying and preparing the
invitations for mailing; (c) cost of mailing the 640 invitations to Kinder Family Clinic
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patients identified as current smokers; (d) time spent by the primary investigator
gathering educational information; (e) time and cost of copying the educational data; (f)
time spent by primary investigator with each participant completing survey, providing
educational material, e-cigarette information, and smoking cessation counseling; (g) time
spent by primary investigator performing follow-up phone calls to each participant at two
weeks, one month, three months, and six months; (h) projected cost to health care system
if they kept smoking; and (i) reimbursement for the smoking cessation program clinic
visits based on payor source.
Data Collection and Analysis
Specific tools were used to assess the degree to which each program goal was met
as well as the specific evaluation questions. In some cases, standardized tools were used
while other evaluation questions required survey tools developed specifically for this
program.
•

An electronic health record system (Practice Partner EHR) was used to
identify potential participants and collect and maintain patient data/
information throughout the program.

•

The main frameworks used for evaluating this program were the
Donabedian (1972) model and the bridge evaluation model (Sieloff, 1999).

•

The TTM model Five Stages of Change evaluated a participant’s readiness
to quit.

•

The Fagerstrom Tolerance Test was used to evaluate participants’ nicotine
addiction level and to recommend baseline nicotine dose.
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•

The participant survey that included questions on demographic information,
smoking history, previous quit attempts, and methods tried was provided to
each participant at initiation of program.

•

Education material on the effects of smoking and benefits of quitting was
accessed through the Colorado Collaborative Clinical Guidelines (2004).

•

Informational materials were provided to participants regarding
effectiveness, cost, and potential side effects of different cessation methods.

•

Information was provided on the two chosen e-cigarettes (Blu Cig and
Smoke Tip) used in this program regarding cost, nicotine doses and flavors,
and accessibility.

•

Phone calls were made to participants during implementation and at
completion of program regarding smoking status, decrease in number of
cigarettes if still smoking, nicotine level if using e-cigarette, and comments
regarding e-cigarette likability, usability, durability.
Recommendations

Following systematic analysis of the data, recommendations were developed
regarding how to continue this program more effectively. The data interpretation was
conducted to determine what elements of the program should undergo revisions,
additions and/or deletion, and what other potential options exist for effective
implementation (e.g., other settings, use of different types of staff). Finally, outcome
measures were interpreted to determine feasible program goals for the future.

CHAPTER IV

RESULTS

Presentation of the results of the program evaluation are organized based on the
purpose of the evaluation and the five primary evaluation questions as outlined in
Chapter III: Evaluation Plan. This results chapter describes the achievement of the
program goals, effective program components, potential program improvements, cost
effectiveness, and program outcomes. The findings are also presented using
Donabedian’s (1972) model of structure, process, and outcomes.
Data Analysis and Findings
Q1

Were the stated goals of the program met, not met, or partially met?

Each program goal (outlined in Chapter II) was assessed based on appropriate and
applicable data. Table 6 shows whether each program goal was met, partially met, or not
met.
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Table 6
Goals and Objectives Met, Partially Met, or Not Met
Goal

Recruit patients from
Kinder Family Clinic
Practice and the
surrounding
community who were
willing to participate in
the program.

Obtain pre-intervention
assessment of
participants to
determine smoking
history, demographics,
likelihood to change
and be successful, and
baseline nicotine dose.

Met,
Partially
Met or
Not Met
Met

Objective

•
•

•

Partially
Met

•

•

•

Implementation of a
structured, systematic
smoking cessation
program using the
“Five A’s” Treating
Tobacco Use and
Dependence to include
options to either help
smokers quit entirely
or switch from tobacco
cigarettes to electric
cigarettes (Appendix
E).

Met

•
•

•
•

•

•

•

•

Identify Kinder Family Clinic patients who are current smokers using
the clinic’s EHR system “Practice Partner”.
Send a survey to those patients identified as current smokers.
(Appendix A). Based on return survey results, identify patients who
were willing to participate in the program who wished to quit, or who
were willing to switch from tobacco cigarettes to e-cigarettes.
Provide each participant with informed consent regarding program to
read and sign prior to participation.

Met,
Partially
Met or Not
Met
Objective
results
addressed
in
Structure,
Process,
and
Outcomes
Measures.

Evaluate participants’ stage of change, smoking status, length of time
they smoked, number of cigarettes per day, previous attempts to quit,
past interventions used for smoking cessation, demographic
information including age, gender, education level. (A former smoker
was defined as an individual that was actively trying to quit and had
not smoked in at least 24 hours.)
Build The Stages of Change questions (Appendix C & D), into the
smoking cessation template in Practice Partner EHR, and use as the
framework for this program to assist in evaluating an individual’s
readiness to quit smoking. Knowing which stage of change an
individual is in was thought to help tailor the information and guidance
provided to maximize success with smoking cessation.
Evaluate nicotine dependence using the Fagerstrom Nicotine Tolerance
Test (RTQ). (This test was used to determine the baseline nicotine
dose for e-cigarettes for smoking cessation (Appendix B).

Objective
results
addressed
in
Structure,
Process and
Outcomes
Measures.

Develop program by reviewing current literature for best practices in
smoking cessation related to addiction, frameworks for behavior
change, NRTs and prescription medications, and patient education.
Adopt and adapt selected education materials based on The "5 A's"
model (Appendix E), for treating tobacco use and dependence that was
developed by the Colorado Collaborative Clinical Guidelines
(Colorado Collaborative Clinical Guidelines, 2004).
Provide staff development and education regarding program details,
patient data, and Practice Partner EHR prior to implementation.
Discuss options for smoking cessation with each participant at
initiation of program, and allow the participant to choose which
cessation method he or she would like to try. Provide written
information on different cessation options, success rate, risks, and
benefits at the initiation of the program.
Provide written information on dangers of smoking and benefits of
quitting, support, and resources to help with quitting at the initiation of
program to each participant (Colorado Collaborative Clinical
Guidelines, 2004).
Develop a plan and timeline to decrease nicotine dose based on
nicotine dependence, personal preference, desire to quit, and health
risks for each participant and evaluate their nicotine dose during each
follow-up phone call.
If the participant chose to try e-cigarettes, provide written information
on “blu cig” and “smoke tip” e-cigarettes, which were the two ecigarette brands recommended for this program, regarding cost,
availability, nicotine dosage options.
Develop and implement a follow-up plan that integrates phone calls or
office visits for each program participant at 2 weeks, 1 month, 3
months, and 6 months. Document follow-up data in Practice Partner
EHR (Appendix G) that includes evaluation questions regarding
smoking status, nicotine dosage, e-cigarette likability, usage, and
comments.

Objective
results
addressed
in
Structure,
Process and
Outcomes
Measures.
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The program was successful in meeting many of the goals and objectives that
were outlined. As planned, all 640 identified patients who were current smokers at
Kinder Family Clinic were sent an invitation to participate in the smoking cessation
program. However, of the 640 who were invited to participate, only 48 chose to do so
and 44 completed the program. All participants completed the pre-participation survey,
were provided educational material on smoking cessation and e-cigarettes, were
evaluated on their stage of change, and were provided the Fagerstrom nicotine tolerance
questionnaire to determine baseline nicotine dose. Interviews with staff revealed they
perceived they were adequately educated regarding details of the program. The chosen
method of follow-up contact by phone was not effective as only 10 (21%) of the
participants were successfully contacted at all four follow-up calls and four (8%) were
not contacted at all. The remaining 34 (71%) were successfully contacted at least once.
The electronic health record platform, Practice Partner, was found to lack the capabilities
to successfully track multiple patients with multiple data points. Thus, a separate Excel
spreadsheet was created to document and track the data for this program.
Q2

Were the structural components (facility/setting, human resources,
organizational resources, EHR, tools) effective and how did they
contribute to the value of the program?

Table 7 shows whether the structural components were effective and contributed
value to the program.
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Table 7
Effectiveness and Value of Structural Measures to the Program
Measure
Usefulness of written
education on smoking
cessation.
1. Packet from
Colorado
Collaborative
Guideline

Effectiveness

Ineffective

Notes/Value to the Program
The education material on the effects of smoking and benefits of
quitting provided to all participants which was obtained through the
Colorado Collaborative Clinical Guidelines was actually found to be
quite ineffective at increasing success rate of quitting or switching to ecigarettes within this participant group (Colorado Collaborative Clinical
Guidelines, 2004).
At the completion of the program, only two participants stated they had
called the Colorado Quit Line, one stated “they were a joke”, and the
other said “they weren’t very helpful and they weren’t supportive of ecigarettes so I never called back.” The Colorado Quit Line is a state
funded program and does not recognize or support e-cigarettes as
cessation method. For this type of program it is thought that the
information provided by the State of Colorado on tobacco cessation
would not be the most effective or appropriate regarding the use and
recommendations for e-cigarettes as a NRT for smoking cessation or
harm reduction.

2. Smoking Cessation
Options and Cost
Comparison of
NRT.

Effective

All 44 participants questioned at the completion of the program
regarding the informational material provided regarding effectiveness,
cost, and potential side effects of different cessation methods stated they
thought it was effective and informative, especially when comparing the
cost of different NRT (Appendix G). Ten of the participants
commented on the cost of the approved NRT vs. e-cigarettes and how
much cheaper e-cigarettes were.

3. Information on
BluCig and
SmokeTip
E-cigarettes

Partially
Effective

Eight participants also stated that the information provided on the two
chosen e-cigarettes (BluCig and SmokeTip) that were used in this
program regarding cost, nicotine doses and flavors, and accessibility
were helpful.
There were multiple comments regarding how much cheaper ecigarettes were compared to tobacco cigarettes and several participants
commented that was a reason to switch in itself.
However, this information should have been much more inclusive
regarding different brands, nicotine doses, cost, and accessibility of ecigarettes. One of the recommended brands for this program was only
available through the internet which was thought to decrease its
usability. One of the local brands which came highly recommended by
five of the participants was the “Mystic” e-cigarette, which could be
found at multiple convenience stores and Walmart. The cost of the kit
was approximately $30 (includes three nicotine cartridges, two ecigarette batteries, and a wall charger). The replacement cartridges
come in three different strengths (1.4 mg, 1.8 mg, and 2.4 mg) and the
cost is $13/5 cartridges or $20/10 cartridges regardless of nicotine dose.
The cost savings on these replacement cartridges is equivalent to
$2.00/pack of cigarettes compared to the average price of $5.00/pack of
cigarettes, or a $3.00 savings per pack. Based on this participant
feedback, the “Mystic” e-cigarette would be recommended due to easy
availability, and cost savings related to tobacco cigarettes.

(Table continues)

40
Table 7 Continued
Measure
Usability and reliability
of EHR “Practice
Partner” for data
collection and analysis.

Effectiveness

Notes/Value to the Program

Partially
Effective

Upon review of Practice Partner EHR, it was found to be easy to use for
individualized data but the system was not able to adequately or
accurately track and quantify data regarding multiple patients in a
reliable way.
An Excel spreadsheet was used at the completion of this program to
quantify results.
For future program participation within this same setting, or in other
settings, a better program is recommended that can more accurately
identify current smokers within the practice and that is able to
accurately and easily track participants and the related information.

Staff education
regarding Kinder
Family Clinic smoking
cessation program.

Effective

Focused questions to staff determined that they felt they were
adequately informed and educated regarding program

Usefulness of the TTM
model Five Stages of
Change Framework
used for program.

Ineffective

The TTM model Five Stages of Change that was used to evaluate a
participant’s readiness to quit, was not found to be an effective tool for
this program, as all participants were found to be in the “action stage”
or they would not have participated in the program.
The TTM model could be still be used in a clinic setting to identify
what stage of change a current smoker is in, and their readiness to quit
or willingness to even receive cessation information/education.
It could be used along with the “5 A's” to encourage patients to quit
smoking at each health care visit, but is not recommended as the basis
for this type of cessation program (Colorado Collaborative Clinical
Guidelines, 2004).

Fagerstrom Tolerance
Test effectiveness,
reliability, validity, and
accuracy of to measure
nicotine addiction level
of program
participants.

Effective

The Fagerstrom Tolerance Test was used to evaluate participants’
nicotine addiction level and to recommend baseline nicotine dose. This
was an excellent tool to use to evaluate addiction level and choose
appropriate baseline nicotine dose to prevent withdrawal symptoms,
which is the most common reason to start smoking tobacco cigarettes
again (Fagerstrom, Hughes, Rasmussen, & Callas, 2000).
This tool was found to be easy to use and understand, applicable, and an
effective way of determining baseline nicotine levels. The correlation
between the nicotine level on the FTT and what the participant stated
they used was consistently the same.

Pre-participation
Survey
1. Questionnaire
2. Mail Survey

Partially
Effective

The participant questionnaire included questions on demographic
information, smoking history, previous quit attempts, and cessation
methods tried. It was found to be an effective method to collect baseline
data; however, it is recommended that a follow-up questionnaire be
provided to all participants at the end of the program.
It is also recommended to create multiple or alternative methods of
communication with participants such as email, website, or text
messaging, instead of limiting communication to phone or in office
follow-up. It is felt this would have improved the participation rate and
the follow-up contact.

(Table continues)
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Table 7 Continued
Measure
Phone calls as chosen
method of contact and
follow-up with
participants.

Effectiveness

Notes/Value to the Program

Partially
Effective

The follow-up method chosen for this program was found to be a poor
choice. It was limited strictly to phone calls at two weeks, one month,
three months, and six months after each participant started the program.
The success rate of contact at each planned follow-up was only 10 of 44
participants or 23%. However, all but four participants were contacted
at least once during the program, so overall the successful participation
was 92%. Unfortunately, since this program was limited strictly to
phone contact, two of the four participants that were never contacted,
had the wrong phone number listed for their contact information. Had
there been other methods of contact implemented at the start of the
program the successful follow-up rate could have been 100%.
The follow-up questions regarding current smoking status, decrease in
number of cigarettes if still smoking, nicotine level if using e-cigarette,
comments regarding e-cigarette likability, usability, durability were
found to be helpful and appropriate. However, it is thought that there is
some other important information that could have been gathered from
participants’ opinion regarding appropriate frequency of follow-up
contact, preferred method of contact, preferred duration of the program,
and recommended support material or advice

Necessary
qualifications and bias
of program
administrator/provider.

Partially
Effective

The primary investigator for this program was a certified Family Nurse
Practitioner with 20 years of nursing experience, and 12 years’
experience as a nurse practitioner working in a rural setting and treating
chronic disease, tobacco abuse and its multiple related health problems.
Although this experience and education was beneficial to the
development and implementation of the initial program, it is thought
that this program could be implemented by multiple individuals with
varying levels of education or experience.
This program could easily be implemented by multiple staff members,
such as a medical assistant, licensed practical nurse, or even
receptionist, and overseen by a primary care provider. Once the
structure is developed for the program, any interested party could
provide the necessary ongoing education and follow-up.
There could be bias on the side of the primary investigator due to the
fact that the same individual developed, implemented, and evaluated the
program. Steps to remove or limit bias included having a set structure
to the program, ensuring the same information, questionnaire, and
educational material was provided to all participants in the same
manner, and that all names or other identifying information were
removed from the results.

Program Sustainability
and Usability

Effective

This program could be useful in multiple settings. Due to the financial
benefits, and the accessibility of e-cigarettes this program could be used
in several health care settings such as indigent and urgent care clinics,
private and specialty clinics, public health facilities, hospitals, and long
term care facilities.
The fact that, at this time, e-cigarettes can be used in places where
tobacco cigarettes are prohibited and that they are less than half the cost
of tobacco cigarettes and other NRT (Appendix G) makes e-cigarettes
an affordable, accessible, cheaper NRT option. The main constraint
that would inhibit the use of e-cigarettes in any government funded
facility is that they are not an FDA approved NRT and probably never
will be.

42
Q3

Were the processes used for the program effective and how did they
contribute to the value?

Table 8 indicates the processes used for the program, whether they were effective,
and how they contributed to the value of the program.
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Table 8
Effectiveness and Value of Process Measures to the Program
Measure

Effectiveness

Notes/Value to the Program

Identify all current smokers at Kinder
Family Clinic and those willing to
participate in smoking cessation program.

Partially
Effective

Kinder Family Clinic 3000 patients: 640
identified as current smokers and sent
invitation to participate in program.
(Equivalent to the national and state average
at 21% (CDC, 2012).
48 responded to invitation and started
program (7.5% of smokers (Practice Partner
Electronic Health Records, 2011).
44 participants finished program (6.9%.
Though this participation rate was quite
dismal, it was higher than the national
average of 4 % (CDC, 2012).
However, due to misinformation on the part
of patients, failure to document on the part
of Kinder Family employees, or failure of
Practice Partner EHR to accurately track
this information, it is possible and probable,
that the actual number of current smokers is
much higher.

Usefulness of The Stages of Change and
participation in program.

Ineffective

All participants were in action stage in at the
initiation of the program.
At completion of program, seven
participants were still smoking or had
started smoking so were no longer
considered to be in the action stage but back
in the contemplation or pre-contemplation
stage.
Of the remaining 37 participants 21 of them
had quit (14) or switched to e-cigarettes (7)
so were considered to be in the maintenance
stage.
The remaining 16 participants had either cut
down to smoking less than half of where
they started (3) or had cut down to less than
half and were using e-cigarettes (13) at the
completion of the program so were still
considered to be in the action stage.

Usefulness of determining nicotine
addiction level of participants at initiation
and completion of program.

Effective

Determining participants” nicotine addiction
level at the onset of the program was helpful
in determining their baseline nicotine dose
for e-cigarette and correlated with their
successful cessation rate or ability to switch
to e-cigarettes.
(table continues)
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Table 8 Continued
Measure

Effectiveness

Notes/Value to the Program

Determine whether all participants
received educational handouts at initiation
of program.
1. Information on effects of smoking and
benefits of quitting.
2. Information on NRT options and cost
comparison.
3. Information on e-cigarette options,
cost, availability, nicotine dosage, and
flavor options.

Effective

Through evaluation of EHR documentation
and participant response it was determined
100% of participants were provided
educational material.

Phone Call Follow-up Response of
participants.

Partially
Effective

Number of participants contacted all 4
attempts = 10 (21%)
Number of participants contacted on 3
attempts = 11 (23%)
Number of participants contacted on 2
attempts = 7 (15%)
Number of participants contacted on 1
attempt = 16 (33%)
Number of participants never contacted = 4
(8%)
Total participants contacted at least once
= 44 (92%)

Q4

What were the outcomes of the program and how do they compare with
anticipated outcomes and outcomes of other standard practices?

Kinder Family Clinic has a patient population of 3,000; of this patient group, 640
(21%) were identified as current smokers. Of the 640 current smokers who were sent an
invitation to participate in the Kinder Family Clinic Smoking Cessation Program, 48
responded and started the program; 44 (92%) completed the program. Of the 44
participants who completed the program, 15 were male and 29 of them female. All 44
participants were non-Hispanic/White and ranged in age from 20-75; the largest
percentile (30%) were in the 51-60 age group and 25 (57%) had a high school education
or less (see Table 9).
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Table 9
Participant Demographics
Participant

Male

Female

Total
Percentile

Age
20-30
3140
41-50
51-60
61-70
71 and Over
Total

3
3
4
3
2
0
15

3
5
4
10
5
2
29

6
8
8
13
7
2
44

Race/Ethnicity
Non-Hispanic/White

15

29

44

Education Level
Some High School
High School Diploma/GED
Trade School
Associate’s Degree
Bachelor’s Degree
Master’s Degree

2
7
5
1
0
1

4
12
2
7
2
1

6
19
7
8
2
2

The participants were provided the Nicotine Tolerance Test (RTQ) at the
initiation of the program to determine baseline nicotine level. The participants were
provided the RTQ at the initiation of the program to determine baseline nicotine level.
Of the 44 participants who completed the program, 39 (89%) were determined to be at
either the full strength or light strength nicotine dose. Upon completion of the program
six months later, only 23 (52%) participants were still using either the full or light
nicotine dose and 16 (36%) had decreased down to placebo (0 mg) level (see Tables 10,
11, and 12).
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Table 10
Nicotine Addiction Levels of Participants at Initiation of Program and at Six Months
Categories of RTQ
scores (nicotine
levels) for all
participants
N= 44

# of Participants
based on RTQ
scores at
beginning of
program

# of Participants
based on RTQ
scores
who did not
complete
program

# of Participants
based on RTQ
scores at
completion of
program
(6 months)

Full (16 mg)

22

2

12

Light (12 mg)

21

2

11

Ultra Lights (8 mg)

5

0

5

Placebo ( 0 mg)

0

0

16

Total

48

4

44

Note. N = 44.

Participants who completed the six-month program had either stopped smoking
tobacco cigarettes and no longer used other cessation interventions, stopped smoking
tobacco but continued to use either e-cigarettes, or a combination of e-cigarettes and
medication (see Table 11).
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Table 11
Nicotine Levels of Participants Following Completion of Smoking Cessation Program
Nicotine Levels

Beginning of
Program

Completion of
Program (6
months)

Nicotine levels of participants who quit smoking
tobacco and no longer use e-cigs or medication
Full (16 mg)
Light (12 mg)
Ultra Light (8 mg)
Placebo (0 mg )
Total

7
4
1
2
14

Nicotine levels of participants who switched to
e-cigarettes
Full
Light
Ultra Light
Placebo
Total

6
0
1
0
7

4
2
1
0
7

Nicotine levels of participants who were using
both tobacco cigarettes and e-cigarettes
Full
Light
Ultra Light
Placebo
Total

3
9
1
0
13

2
8
3
0
13
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Table 12
Success Rate of Participants Using E-cigarette as Tobacco Cessation Method
Choice of
Cessation
Method at
Beginning of
Program

Total

Quit Both
Tobacco
Cigarettes
and Ecigarettes

Switched
Completely to
E-cigarettes

Still
Smoking
Same
amount of
Tobacco
Cigarette

Cut
Down to
< Half

Smoking and ECigarette/ Cut
Down to < Half
of Tobacco
Cigarette

E-Cigarette
Brand
BlueCig
SmokeTip
Other

5
6
15

1
3
6

2
1
0

0
1
4

0
0
1

2
1
4

E-Cigarette &
Bupropion
BluCig
SmokeTip
Other

2
5
9

0
1
1

0
1
3

0
1
1

0
0
2

2
2
2

E-Cigarette &
Chantix
Blu Cig
Smoke Tip
Total

1
1
44

1
1
14

0
0
7

0
0
7

0
0
3

0
0
13

The use of e-cigarettes for smoking cessation was determined to be a successful
alternative to other NRT. Fourteen participants (32%) quit smoking both tobacco and ecigarettes and seven (16%) switched to e-cigarettes and were no longer smoking tobacco
cigarettes. This indicated a success rate for smoking cessation of 48%f, which was much
higher than the national average of only 25% (CDC, 2009). Of the remaining 23
participants, 13 of those (30%) successfully cut down to less than half of their starting
tobacco use level with the use of e-cigarettes, thus showing a large decrease in their harm
reduction level. Of the 14 participants who quit, 10 used e-cigarettes exclusively, two
were also using Bupropion and two were also using Chantix. Of the seven who switched
to e-cigarettes, three were only using e-cigarettes and four were using e-cigarettes and
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Bupropion. Of the 13 participants who cut down to less than half of starting amount of
tobacco cigarettes, seven were only using e-cigarettes and six were using e-cigarettes and
Bupropion.
Q5

Was the program cost effective?

Table 13 presents information concerning the cost effectiveness of the smoking
cessation program.
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Table 13
Cost Effectiveness of the Smoking Cessation Program
Measure

Actual (Possible)
Cost
$22

Reimbursement
$0

Done by receptionist ($11/hr x 2
hours)

Time spent on copying and
preparing the invitations for
mailing.

$33

$0

Done by receptionist ($11/hr x 3
hours)

Cost of mailing the 640
invitations to Kinder Family
Clinic patients identified as
current smokers.

$288

$0

640 x .45 = $288
If invitation sent via text,
email, or posted on website it
would have been free.

$200 ($30)

$0

Primary Investigator ($50/hr x 4
hours). This would not need to
be collected again for
continuation of program, and
any updates or additions to
material could easily and
effectively be done by ancillary
staff.
Medical Assistant ($15/hr x 2
hours = $30)

Time and cost of copying the
educational data

$22

$0

Done by receptionist ($11/hr x 2
hours)

Time spent by primary
investigator with each
participant completing
survey, providing educational
material, e-cigarette
information, and smoking
cessation counseling.

$800 ($60)

$2400

48 x $50 = $2400
20 min appointment per
participant = 16 hrs total/$150 hr
Primary Investigator ($50 hr x
16 hours = $800)
Medical Assistant (Group visit
x 4 x $15/hr = $60)
The re-mbursement rate for the
office visit for Tobacco
Cessation is approximately $50,
depending on which commercial
insurance.
Group visits would be a much
more cost effective alternative,
and could be done by ancillary
staff.
(table continues)

The human resources or time
spent collecting “current
smoker status” on Kinder
Family Clinic patients from
Practice Partner EHR.

Time spent by the primary
investigator gathering
educational information.

Notes/Comments
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Table 13 Continued
Measure
Time spent by primary
investigator performing
follow-up phone calls to each
participant at two weeks, one
month, three months, and six
months.

Total

Projected cost to health care
system if they kept smoking

Actual (Possible)
Cost
$1600 ($150)

Reimbursement

Notes/Comments

$0

Primary Investigator ($50 hr x
32 hours = $1600)
Medical Assistant ($15/hr x 10
hours = $150). Time spent on
phone calls, and sending and
replying to emails, text
messages, and website.
Follow-up phone calls could
have been done by ancillary staff
making it much more affordable,
and if alternative methods of
follow-up (email, website, text
messages) had been an option
that would have also make
program more cost effective.

$2965 ($605)

$2400

Although the actual costs
showed a loss of $565 on the
program, had it been set up
differently so that ancillary staff
were responsible for most of the
participate information, group
visits vs individual visits, and
alternative means of
communication the cost of
program implementation would
be much lower and would have
actually show a profit of $1795
or more.

Hard to
quantify.

Hard to
quantify.

The actual savings to health care
system is hard to measure, but
could be substantial if the death,
disease, and disability related to
cigarette smoking were reduced
by half what the current statistics
show. It would also reduce
deaths and disease related to
secondhand smoke exposure

The following positive comments and recommendations were made regarding ecigarette satisfaction, reliability, cost, and improvement to quality of life:
•

“Blu Cig is not the same but effective. I quit completely using it.”

•

“Blu Cig does help alleviate desire to smoke, but still smoking a few regular cigarettes a
day.”
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•

“E-cigarettes too heavy, needs to hang from lip more comfortably, but I like the nicotine
part and feel like I got my nicotine fix okay.”

•

“It doesn’t compare to the real thing but it helps relieve nicotine cravings really well.”

•

“It really helps when I can’t smoke a regular one and I have cut down to 2-3 regular
cigarettes a day.”

•

“I like the price! It really helped my breathing and diabetes, makes me want to move
around more.”

•

“Definitely takes craving away and helps if you want to quit.”

•

“I think they work when I use them, but I’m not completely quit, down to 2-3 tobacco
cigarettes/day.”

•

“Taste much better than a cigarette! I like the cinnamon as doesn’t remind me of a cigarette,
but they are much harder to draw, and heavier than I would like.”

•

“I decided to just “switch brands” to e-cigarette, still using daily, haven’t had a regular
cigarette in 3 months and I don’t want one.”

•

“I’m down to less than a pack from 2 pack/day using my e-cigarette. I use it every day and
really think I can quit completely using it.”

•

“I cut down to less than half on tobacco cigarettes using my Blu Cig, still using daily, but I
don’t like how heavy they are.”

•

“I think they work well, but I don’t like how heavy they are.”

Only three negative comments were given by the participants: “I just didn’t like
them; I don’t like the taste or the feel of them,” “I hate e-cigs; they don’t taste anything
like cigarettes,” and “Didn’t help with craving at all.”
Challenges and Unintended Consequences
Specific challenges existed related to the practice setting for this program given
the rural nature and patient demographics. Most of the participants had a high school
education or less and many worked at blue collar jobs. Evidence showed that this group
had the highest rate of smoking and was the group least likely to quit (CDC, 2012). The
specific opportunity related to this program was the small population that chose to
participate. Most of the individuals who chose to participate in this program were
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previously established patients at the health care with a prior established relationship with
the primary investigator. This conceivably made them more willing to participate in the
program, consider smoking cessation options, or at least be willing to try the e-cigarette
as an alternative to tobacco cigarettes.

CHAPTER V

RECOMMENDATIONS AND IMPLICATIONS
FOR PRACTICE

Based on the results of this project evaluation, I strongly recommend this program
continue in its current setting and be shared with other agencies and institutions.
Unfortunately, the participation rate was only 7.5% of the 640 Kinder Family Clinic
patients who were identified as current smokers. However, 21 (48%) of the 44
participants either quit or switched to e-cigarettes. While smoking cessation provides the
greatest risk reduction, switching to e-cigarettes substantially decreases the risk of
tobacco related conditions. Of the remaining 23 participants, 13 had cut down to less
than half of their previous smoking level and only seven were still smoking the same
amount at the end of the program as when they started. This success rate is double both
the national and state averages of 21 and 24%, respectively (CDC, 2009).
This program should also be expanded and extended outside the scope of the
Doctor of Nursing Practice program to increase the success rate of Kinder Family Clinic
patients for smoking cessation or harm reduction. The focus should include an ongoing
evaluation of patients who choose to participate in the program and their continued
success rate with cessation or harm reduction should be documented at least annually in
their EHR.
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Summary of Evaluation Findings
and Recommendations
The program evaluation resulted in the following recommendations:
•

For future programs within this same setting or in other settings, use a
different EHR system or data collection program that can more easily and
accurately identify and track data from multiple participants at multiple
points.

•

Have multiple staff members involved in the education and counseling of
participants and the collection of follow-up data.

•

For cost effectiveness, have a primary care provider oversee the program
and have ancillary staff implement the program.

•

Provide multiple methods of contact to participants including phone, in
office follow-up, text, email, and website at the initiation of the program and
follow-up according to participant preference.

•

Find an alternative tool to the TTM for this type of program to encourage
increased participation.

•

Continue using The Fagerstrom Tolerance Test as a tool to evaluate
addiction level and choose appropriate baseline nicotine; this tool was
determined to be reliable, applicable, and an effective way of determining
baseline nicotine levels.

•

Continue use of a baseline participant questionnaire including questions on
demographic information, smoking history, previous quit attempts, and
cessation methods tried; however, standardize the process so the same
questionnaire is provided to all participants at the end of the program. It is
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also recommended that information regarding appropriate frequency of
follow-up contact, preferred duration of the program, and recommended
support material or advice be asked of participants.
•

Find alternative educational material on the effects of smoking and benefits
of quitting for this type of program; it is not recommended to refer
participants to the Colorado Quit Line as they do not support the use of ecigarettes as a cessation method at this time.

•

Continue providing informational material regarding the effectiveness, cost,
and potential side effects of different cessation methods as many
participants found this information helpful. It is also recommended to
continue providing information regarding different brands, nicotine doses,
cost, and accessibility of e-cigarettes but to include more information on the
cost and accessibility of local options.

•

Continue the program in its current setting with the above changes and share
this program with any other agency or institution interested in using ecigarettes as a smoking cessation option or a harm reduction method.
Implications for Practice

I plan to use the results from this study to continue to improve the health of my
patients through the use of e-cigarettes as a smoking cessation method or as a “harm
reduction” method by switching from tobacco cigarettes to e-cigarettes. I also plan to
share the results of this project with other clinicians. The American Association of
Public Health Physicians, The Department of Community Health Sciences, The
American Council on Science and Health, and The Tobacco Harm Reduction Research
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Committee currently support the use of e-cigarettes for use in smoking cessation. I
intend to disseminate my results with those entities and others in the hopes of conducting
further research on the use of e-cigarettes as a smoking cessation method or as a harm
reduction method.
Implications for practice based on the evidence gained from this study could be
significant. The e-cigarette completely alleviates the health risks related to second hand
smoke and dramatically reduces or alleviates the risks to current smokers by removing
the carcinogens found in tobacco cigarettes. E-cigarettes are also much cheaper than
tobacco cigarettes. A smoker can slowly reduce the amount of nicotine until they are at a
placebo level, thus reducing or alleviating the symptoms of nicotine withdrawal. Ecigarettes provide a new alternative to other NRT options, they are the most like tobacco
cigarettes in their delivery form, they are the one of the most affordable NRT options
available, and individuals can use them as a smoking cessation option or as a harm
reduction method.
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SMOKING SURVEY
1.

Current Smoker ________

Former Smoker (actively trying to quit, has been at least

24 hours since last cigarette)______________
2. Have you tried to quit? Yes____

No_____

How Many Times?_______

3. What have you tried to help you quit? (Check all that apply)
Nicotine Patches____________
Nicotine Gum ______________
Nicotine Lozenges __________
Nicotine Nasal Spray ________
Nicotine Inhaler ____________
Chantix ___________________
Zyban/Bupropion ___________
“Cold Turkey”______________
Electric Cigarettes ___________
Other _____________________
4.

What method/methods were most successful in helping you quit? __________________
_______________________________________________________________________

5. Are you interested in trying to quit again? Yes____

No____

6. Would you be interested in participating in a study evaluating the above cessation
options, or would you be interested in switching to an electric cigarette to reduce the
health risks of the harmful carcinogens found in tobacco cigarettes? Yes____ No_____
7.

Male_____
Female_____
Hispanic____

Age______

Ethnicity: Hispanic___ Non-

Race: White___ African American___ Native American____ Asian/Pacific Islander___
8. Education Level: (mark highest level)
Some High School_______________
High School Diploma ____________
Trade School___________________
Associates Degree _______________
Bachelor’s Degree _______________
Master’s Degree _________________
Doctorate ______________________
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INFORMED CONSENT TO PARTICIPATE
IN RESEARCH
Identification of Investigators & Purpose of Study
You are being asked to participate in a research study conducted by Jona Ely, FNP-C at
Kinder Family Clinic, and Doctor of Nursing Practice student at the University of
Northern Colorado. The purpose of this study is to evaluate whether electric cigarettes
are an effective smoking cessation alternative. This study will contribute to the
researcher’s completion of her capstone project and doctoral degree.
Research Procedures
Should you decide to participate in this research study, you will be asked to sign this
consent form once all your questions have been answered to your satisfaction. This study
consists of a survey and interviews that will be administered to individual participants at
Kinder Family Clinic or by phone. You will be asked to provide answers to a series of
questions related to your previous and present smoking habits, smoking cessation
options, and interest in quitting. You will also be provided information on all currently
approved smoking cessation options plus electric cigarettes. If you chose a prescription
alternative you will be provided a prescription and recommendations for follow-up. You
may also chose to try more than one cessation option at a time as that has been shown to
be more effective.
Time Required
Participation in this study will require your participation in an initial evaluation, and a
follow-up phone call or office visit (as deemed appropriate related to your health history
and needs) at two weeks, one month, three months, six months, and one year.
Risks
The investigator does not perceive more than minimal risks from your involvement in
this study. Electric cigarettes have not been shown to have any greater health risks than
tobacco cigarettes. However, at this time they are not currently approved as a smoking
cessation option and have not been proven to be safe or effective.
Benefits
Potential benefits from participation in this study include complete smoking cessation; or
a decrease in health related risks by switching to a safer alternative than tobacco
cigarettes; a financial benefit related to decreased cost of e-cigarettes compared to
tobacco cigarettes; alleviation of secondhand smoke effects; and convenience of being
able to use e-cigarette anywhere.
Confidentiality
The results of this research will be included in the investigator’s capstone evaluation and
outcomes. The results of this project will be coded in such a way that the respondent’s
identity will not be attached to the final form of this study. The researcher retains the
right to use and publish non-identifiable data. While individual responses are
confidential, aggregate data will be presented representing averages or generalizations
about the responses as a whole. All data will be stored in a secure location accessible
only to the researcher. Upon completion of the study, all information that matches up
individual respondents with their answers will remain in the patient’s electronic health
record at Kinder Family Clinic.

70
Participation & Withdrawal
Your participation is entirely voluntary. You are free to choose not to participate.
Should you choose to participate, you can withdraw at any time without consequences of
any kind.
Questions about the Study
If you have questions or concerns during the time of your participation in this study, or
after its completion, or you would like to receive a copy of the final aggregate results of
this study, please contact:
Jona Ely, FNP-C
Kinder Family Clinic
Phone: (970) 826-0911
Email: kinderfamilyclinic@yahoo.com
Giving of Consent
I have read this consent form and I understand what is being requested of me as a
participant in this study. I freely consent to participate. I have been given satisfactory
answers to my questions. The investigator provided me with a copy of this form. I
certify that I am at least 18 years of age.

______________________________________
Name of Participant (Printed)

______________________________________
Name of Participant (Signed)

______________
Date

______________________________________
Name of Researcher (Signed)

______________
Date
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MEASURING CHANGE PROCESSES
Forty Core Items Measuring Ten Change Processes With Varimax-Rotated Component Loadings From Two Samples
Item
Consciousness Raising
1 recall articles dealing with the problem of quitting smoking.
I think about information from articles and advertisements on how to stop smoking.
1 recall information people had given me on how to stop smoking.
I recall information people had personally given me on the benefits of quitting smoking.
Self-Liberation
I tell myself can choose to smoke or not.
I tell myself am able to quit smoking if I want to.
I tell myself that if I try hard enough I can keep from smoking.
I make commitments not to smoke.
Dramatic Relief
Warnings about health hazards of smoking move me emotionally.
Dramatic portrayals of the evils of smoking affect me emotionally.
I react emotionally to warnings about smoking cigarettes.
Remembering studies about illnesses caused by smoking upset me.
Environmental Reevaluation
I am considering the belief that people quitting smoking will help to improve the world.
I stop to think that smoking is polluting the environment.
I consider the view that smoking can be harmful to the environment.
I am considering the idea that the world could be a better place without my smoking.
Helping Relationship
Special people in my life accept me the same whether I smoke or not.
I can be open with at least one special person about my experience with smoking.
I have someone who listens when I need to talk about my smoking.
I have someone whom I can count on when I'm having problems with smoking.
Stimulus Control
I remove things from my home that remind me of smoking.
I keep things around my place of work that remind me not to smoke.
I remove things from my place of work that remind me of smoking.
I put things around my home that remind me not to smoke.
Counterconditioning
Instead of smoking, I engage in some physical activity.
I find that doing other things with my hands is a good substitute for smoking.
When I am tempted to smoke, I think about something else.
I do something else instead of smoking when I need to relax or deal with tension.
Social Liberation
I see "No Smoking" signs in public buildings.
I notice that public places have sections set aside for smoking.
I find society changing in ways that make it easier for the nonsmoker.
I notice that nonsmokers are asserting their rights.
Self-Reevaluation
My dependency on cigarettes makes me feel disappointment in myself.
I get upset when I think about my smoking.
I reassess the fact that being content with myself includes changing the smoking habit.
I consciously struggle with the issue that smoking contradicts my view of myself as a caring and responsible person.
Reinforcement Management
I can expect to be rewarded by others if 1 don't smoke.
I am rewarded by others if I don't smoke.
Other people in my daily life try to make me feel good when I don't smoke.
I reward myself when I don't smoke.
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STAGES OF CHANGE MODEL

Stage in transtheoretical
model of change
Precontemplation

Contemplation
Preparation
Action
Maintenance
Relapse

Patient stage
Not thinking about change
May be resigned
Feeling of no control
Denial: does not believe it
applies to self
Believes consequences are not
serious
Weighing benefits and costs of
behavior, proposed change
Experimenting with small
changes
Taking a definitive action to
change
Maintaining new behavior over
time
Experiencing normal part of
process of change
Usually feels demoralized

Incorporating other
explanatory/treatment models
Locus of Control
Health Belief Model
Motivational interviewing

Health Belief Model
Motivational interviewing
Cognitive-behavioral therapy
Cognitive-behavioral therapy
12-Step program
Cognitive-behavioral therapy
12-Step program
Motivational interviewing
12-Step program

Information from Prochaska, J.O., DiClemente, C. C., & Norcross, J. C. (1992). In search of
how people change. American Psychology; 47, 1102-1104, and Miller, W. R, & Rollnick, S.
(1991). Motivational interviewing: Preparing people to change addictive behavior. New
York: Guilford.

PROCESSES OF CHANGE
Process of change
Consciousness raising
Self‐reevaluation
Self‐liberation
Counterconditioning
Stimulus control
Reinforcement management
Helping relationships
Dramatic relief
Environmental re‐evaluation
behaviors
Social liberation
others

Description
Learning about the problem behavior
Determining how one thinks about oneself with
respect to the problem behavior
Making a commitment to act
Substituting alternative behaviors for the problem
behavior
Avoiding the problem behavior
Rewarding oneself
Talking about the problem with people who care
Expressing feelings about the problems
Environmental support for changing problem
Evaluating how the problem behavior affects
(Andersen, 2007)
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CHANGING BEHAVIOR FOR YOUR HEALTH
1. On the line below, mark where you are now on this line that measures change in behavior. Are you not prepared to
change, already changing or someplace in the middle?
Not prepared to change
Already changing

2. Answer the questions below that apply to you.

•

•

•

•

•

•

If your mark is on the left side of the line:
How will you know when it's time to think about changing?
What signals will tell you to start thinking about changing?
What qualities in yourself are important to you?
What connection is there between those qualities and "not considering a change"?
If your mark is somewhere in the middle:
Why did you put your mark there and not further to the left?
What might make you put your mark a little further to the right?
What are the good things about the way you're currently trying to change?
What are the not-so-good things?
What would be the good result of changing?
What are the barriers to changing?
If your mark is on the right side of the line:
Pick one of the barriers to change and list some things that could help you overcome this barrier.
Pick one of those things that could help and decide to do it by _______________________ (write in a
specific date).
If you've taken a serious step in making a change:
What made you decide on that particular step?
What has worked in taking this step?
What helped it work?
What could help it work even better?
What else would help?
Can you break that helpful step down into smaller pieces?
Pick one of those pieces and decide to do it by _______________________ (write in a specific date).
If you're changing and trying to maintain that change:
Congratulations! What's helping you?
What else would help?
What are your high-risk situations?
If you've "fallen off the wagon":
What worked for a while?
Don't kick yourself--long-term change almost always takes a few cycles.
What did you learn from the experience that will help you when you give it another try?

3. The following are stages people go through in making important changes in their health behaviors. All the stages are
important. We learn from each stage.
We go from "not thinking about it" to "weighing the pros and cons" to "making little changes and figuring out how to
deal with the
real hard parts" to "doing it!" to "making it part of our lives."
Many people "fall off the wagon" and go through all the stages several times before the change really lasts.
The Readiness to Change Ruler can be used with patients contemplating any desirable behavior, such as smoking
cessation, losing weight, exercise or substance-abuse cessation.
Information from references 4, 26 and 27. (Zimmerman, Olsen, & Bosworth, 2000)
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The Revised Tolerance Questionnaire (RTQ)
1. How many cigarettes a day do you smoke? (circle one)
10 or less 11-15
16-20
21-25
2. How deeply do you inhale? (circle one)
1
2
3
I do not
Moderately
Inhale

26 or more

4

5
Very Deeply

3. How often do you smoke more in the morning than during the rest of day? (circle one)
1
2
3
4
5
Never
About
Always
Half the
Time
4. How often do you smoke your first cigarette of the day within 30 minutes of waking? (circle one)
1
2
3
4
5
Never
About
Always
Half the
Time
5. How difficult would it be for you to give up your usual first cigarette of the day? (circle one)
1
2
3
4
5
Not
Somewhat
Extremely
Difficult
Difficult
Difficult

6. How difficult do you find it to refrain from smoking in places where it is forbidden (e.g., in church, at
the library, cinema, etc.)? (circle one)
1
2
3
4
5
Not
Somewhat
Extremely
Difficult
Difficult
Difficult
7. How often do you smoke when you are sick with a cold, the flu, or are so ill that you are in bed most of
the day? (circle one)
1
2
3
4
5
Never
About
Always
Half the
Time
8. On average, about how much of each cigarette do you smoke? (circle one)
1/3 or less
½
2/3
¾
9. On average, how often do you inhale? (circle one)
1
2
3
Never
About
Half the
Time

4

ALL

5
Always

10. On average, how often do you hold cigarette smoke in your lungs for a moment or two before
exhaling?
1
2
3
4
5
Never
About
Always
Half the
Time
Scoring: All items are scored on a 5-point Likert scale. The total RQT score is the mean rating across all 10 items. The
higher the score the higher the nicotine addiction level. (Table by Tate and Schmitz, 1993)
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THE “5 A’s” MODEL FOR TREATING TOBACCO USE
AND DEPENDENCE

A

sk about tobacco use Identify and document tobacco use status of every

patient at every visit.

A

dvise to quit in a clear, strong and personalized manner urge

every tobacco user to quit.

A

ssess For current tobacco user, is the tobacco user

willing to make a quit attempt at this time?
For the ex-tobacco user, how recent did you quit
and are there any challenges to remaining
abstinent?

A

ssist For the patient willing to make a quit attempt,

offer medication and provide or refer for
counseling or additional behavioral treatment to
help the patient quit.
For patients unwilling to quit at this time, provide
motivational interventions designed to increase
future quit attempts.
For the recent quitter and any with remaining
challenges, provide relapse prevention

A

rrange All those receiving the previous A’s should receive follow-up.
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Blu cigs is the hip electronic cigarette brand. All flavors are exclusively made in the USA by Johnson Creek
in their FDA registered facility. The new Premium pack adds better functionality, improved performance
and additional technology to enhance the social and individuality aspect of electronic smoke. The starter
kit price for blu cigs is $69.95 - $79.95. We recommend buying a starter kit with 2 batteries or more. This
"2 piece" electronic cigarette model comes with atomizer and cartridge combined called cartomizer.
Visit site to buy
blu cigs Flavors
Tobacco, Menthol,
Cherry, Java, Vanilla

Starter Kit
$69.95 - $79.95
Price(s): (*)
User
Ratings:
Leave a
Review

Overall ( 4.15 )
Battery Life
Smoke/Vapor
Cust. Service
Cost/Value
Rating Trend: (up)
Based on 270 user reviews.

Currently blu cigs does not
offer any general coupon or
Coupon /
discount codes like 10% off.
Promotion
Take advantage of our
Code:
rebate:
Free
Shipping:
Price per
Cartridge

Shipping
~$2

One
Cartridge 250 puffs
equates to:
Money
Back
30 days
Guarantee:
LED Color: blue
blu cigs
1 year
Warranty:

Get FREE

Nicotine Levels
Full 16mg, Light
12mg, Ultra Light
8mg, Zero: 0mg

blu cigs Starter Kit

Blu's smoke juice flavors are
made in the USA!

Misc. Info
* Blue tip
* USA Made Smoke
Juice
* Pack recharges
batteries and holds
cartridges.
* Smallest and
lightest ecig.
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blu cigs Electronic Cigarette Details
What are Blu Cigs? Blu Cigs are the latest in Electronic smoking. The blu cigarette pack offers the
unique ability to charge on the go (blu cig PPC)! Blu Cig is all about giving you the freedom to
smoke anywhere without tobacco and tar!
Blu cigs starter kit includes:
* 1 pack to hold 5 cartridges/cartomizers and charges your batteries on the go!
* 2 electronic cigarette batteries
* 1 wall charger & 1 USB charger
* 5-pack of flavor cartridges in the flavor and strength of your choice
* 30 day money back guarantee and a one year warranty

Advanced Features of the Premium Pack
•
•
•
•

New, patented Social feature
No screw charging with battery management system that continually monitors and
charges the spare battery
Easy charge icons located on the side so you can see the battery level and charging
progress of the pack and spare battery at any time
Mini USB for data management and efficient charging
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SMOKE TIP ELECTRONIC CIGARETTE
SmokeTip delivers the easiest drag system - almost effortless. Replacement cartridges deliver over 250 puffs per
unit. The starter kit price for SmokeTip is $59.95. We recommend to buy a starter kit with 2 batteries or more. This
"2 piece" electronic cigarette model comes with atomizer and cartridge combined called cartomizer. Visit site to
buy
SmokeTip Flavors
Starter Kit
Regular, Menthol,
Price(s): $59.95
Mild Menthol,
(*)
Cowboy, Almond,
User
Apple, Banana,
Ratings:
Overall ( 4.61 )
Cherry, Chocolate,
Battery Life
Clove, Coffee,
Smoke/Vapor
Leave a
Cinnamon, Grape,
Cust. Service
Review
Orange, Peach,
Cost/Value
Pineapple,
Rating Trend: (unchanged)
Strawberry, Vanilla,
Based on 214 user reviews.
Watermelon
10% off purchase:
ecig365PLUS

Coupon /
Promotion
Code:
Free
Shipping:
Price per
Cartridge
One
Cartridge
equates to:
Money
Back
Guarantee:
LED
Color:
SmokeTip
Warranty:

Get FREE Shipping
~$1.59-$1.99

Nicotine Levels
Full Flavor, Light,
Ultra Light, No
Nicotine
SmokeTip Starter Kit

Misc. Info
Great product at low
price

1.25 pack

30 days
red
100% UNCONDITIONAL LIFETIME
WARRANTY

SmokeTip Electronic Cigarette Details
SmokeTip works like traditional cigarette smoking. It delivers the enjoyment of smoking (the touch and taste)
without the harmful 2000+ chemicals or problems caused by tobacco smoke. The exciting new SmokeTip product
design is the key to making this happen. There is no flame with SmokeTip: the small electronic cigarette includes a
rechargeable battery and replaceable cartridges that provide the smoking experience, without tobacco! Inhaling on
the SmokeTip gives all the same sensations of smoking. However, the unit releases only simulated smoke (vapor
mist), that evaporates in the air.
For any reason, at any time, under any circumstance if your SmokeTip battery stops working you get a free
replacement - no gimmicks no hassles! You don't even need a receipt! Please visit SmokeTip's website for details.
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Statement of Mutual Agreement
University of Northern Colorado
DNP Capstone Project
To Evaluate a Rural Smoking Cessation Program that used Electric Cigarettes as a
Cessation Method or for Harm Reduction
Jona Ely
April 2012
Kinder Family Clinic is a private physician owned health care clinic in rural
Northwest Colorado. The clinic is a family oriented service and provides care to all ages
of patients. Most of the individuals in the area have a high school education or less and
most work at blue collar jobs. There is evidence to show that this group has the highest
rate of smoking and is the group least likely to quit.
The goal of this project is to evaluate an already existing structured smoking
cessation program focused on patient assessment, education, and routinely scheduled
follow up in a primary care setting. The purpose of this project is to evaluate this
programs tools, methods, data, and structure to determine whether it was effective in
helping individuals stop smoking or stop using tobacco cigarettes if they are not
interested in quitting.
As both a University of Northern Colorado student and an employee of Kinder
Family Clinic, the author will have access to confidential records of patients evaluated.
Strict confidentiality will be maintained at all times and no patient identifying
information will appear in any printed materials produced or communication of any kind.
Only information regarding how the evaluation process is conducted, statistical data
regarding patient demographics, smoking history, past interventions / treatments used for
smoking cessation, and cessation success will appear.
The DNP Capstone Project will include a final report and abstract along with
potential publication in an appropriate professional journal and oral presentation. Kinder
Family Clinic will retain property rights to any information containing its name. As
community member on the Capstone Committee Dr. Pamela Kinder will agree to
participate in the review and approval of both the proposal and final version of the project
and be present by phone for both defense meetings. Any written and oral communication
regarding the project will be done with the permission of University of Northern
Colorado representative Dr. Catherine Dingley, Capstone Committee Chair.
Signatures:
_______________________________________________________________________
Dr. Catherine Dingley, Capstone Committee Chair
_______________________________________________________________________
Dr. Rhonda Squires
_______________________________________________________________________
Dr. Pamela Kinder, M. D., Owner of Kinder Family Clinic
_______________________________________________________________________
Jona Ely, DNP Candidate

